Lotus Pharm vs EPS Bio Technology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and EPS Bio Technology (4183) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ EPS Bio Technology

0%+226%-72%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYEPS Bio TechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$12.6 million-72.1%
Sep 2026NT$2.77 billion+128.0%NT$34.2 million-31.0%
Aug 2026NT$2.11 billion+81.7%NT$31.7 million-19.1%
Jul 2026NT$2.49 billion+3.9%NT$26.2 million-37.2%
Jun 2026NT$3.4 billion+225.5%NT$36.8 million+6.4%
May 2026NT$2.32 billion+105.8%NT$40.4 million-30.9%
Apr 2026NT$3.09 billion+19.9%NT$28.3 million-22.6%
Mar 2026NT$4.35 billion+173.6%NT$18.9 million-64.8%
Feb 2026NT$2.24 billion+131.5%NT$17 million-42.8%
Jan 2026NT$2.05 billion-5.5%NT$27.5 million-25.3%
Dec 2025NT$2.44 billion+66.9%NT$44.1 million-16.9%
Nov 2025NT$1.06 billion-0.2%NT$30.1 million-38.8%
Oct 2025NT$2.75 billion+46.0%NT$45 million+212.2%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16